DUSP6 and neoplasm: A single oral dose of 10 mg kg−1 RMC-7977 was sufficient to maximally suppress tumour DUSP6 levels (91%) at 8 h, which partially recovered over 48 h, concordant with the decrease in tumour RMC-7977 concentrations (Fig. 3c).